T2D - managing CVD risk factors
Date Published:
Wednesday, March 9, 2022
Duration:
26:14
Rinki Murphy outlines the practical strategies GPs can put in place to enable systematic CVD risk factor management among patients with T2D.
Topics:
- 00:01 Intro
- 00:40 What percentage does CVD risk increase by for the T2D patient?
- 04:29 What is the underlying mechanism at play here?
- 05:35 Helping to mitigate this risk?
- 07:33 Universal screening - how often?
- 11:39 SGLT2i/GLP1RA - What is the data supporting their use?
- 16:40 Is the trial data correct?
- 17:49 CVD risk reduction - which class is most beneficial?
- 19:10 Monitoring – what to be aware of?
- 22:13 Sick day management – criteria for stopping and starting?
- 23:24 Take-home messages
Take-home messages
|
Presenter
Rinki Murphy
Diabetes Physician
Rinki is a Diabetes Physician at Auckland DHB and Counties Manukau Health. Rinki is an Associate Professor in Medicine at the University of Auckland and Principle investigator at the Maurice Wilkins Centre for Biodiscovery. She is a diabetologist at Auckland and Counties Manukau DHB.
This episode is kindly supported by an educational grant from Eli Lilly.
This presentation is intended for qualified health practitioners professional development and should not be relied upon for any other purpose. Any opinions offered are those of the presenter or other speaker and do not necessarily represent the views of Goodfellow Unit.